SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- Novo Holdings, a leading global healthcare and life sciences investor, today announced that it has made an investment...
Leveraging Meta's technologies, WhatsApp is transformed into a pivotal business tool that engages customers across their entire lifecycle, converting initial interest...
Acquisition strengthens SAP, IT Infrastructure Services, and Cybersecurity capabilities, expands Kaizen's presence in Japan, and adds a proven offshore delivery center in India. ...
SYDNEY, Jan. 20, 2026 /PRNewswire/ -- Humanforce, a leading global provider of intelligent, AI-driven human capital management (HCM) solutions for frontline workforces, today announced...